1. Home
  2. AMRX vs WHD Comparison

AMRX vs WHD Comparison

Compare AMRX & WHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • WHD
  • Stock Information
  • Founded
  • AMRX 2002
  • WHD 2011
  • Country
  • AMRX United States
  • WHD United States
  • Employees
  • AMRX N/A
  • WHD N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • WHD Metal Fabrications
  • Sector
  • AMRX Health Care
  • WHD Industrials
  • Exchange
  • AMRX Nasdaq
  • WHD Nasdaq
  • Market Cap
  • AMRX 2.9B
  • WHD 2.9B
  • IPO Year
  • AMRX N/A
  • WHD 2018
  • Fundamental
  • Price
  • AMRX $9.62
  • WHD $42.83
  • Analyst Decision
  • AMRX Strong Buy
  • WHD Buy
  • Analyst Count
  • AMRX 4
  • WHD 4
  • Target Price
  • AMRX $11.50
  • WHD $50.75
  • AVG Volume (30 Days)
  • AMRX 1.6M
  • WHD 642.9K
  • Earning Date
  • AMRX 08-05-2025
  • WHD 10-29-2025
  • Dividend Yield
  • AMRX N/A
  • WHD 1.22%
  • EPS Growth
  • AMRX N/A
  • WHD N/A
  • EPS
  • AMRX 0.01
  • WHD 2.67
  • Revenue
  • AMRX $2,852,914,000.00
  • WHD $1,119,196,000.00
  • Revenue This Year
  • AMRX $9.56
  • WHD N/A
  • Revenue Next Year
  • AMRX $6.27
  • WHD $25.77
  • P/E Ratio
  • AMRX $884.41
  • WHD $15.98
  • Revenue Growth
  • AMRX 9.81
  • WHD N/A
  • 52 Week Low
  • AMRX $6.69
  • WHD $33.80
  • 52 Week High
  • AMRX $9.79
  • WHD $70.01
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 68.88
  • WHD 55.28
  • Support Level
  • AMRX $9.32
  • WHD $39.86
  • Resistance Level
  • AMRX $9.76
  • WHD $42.32
  • Average True Range (ATR)
  • AMRX 0.22
  • WHD 1.29
  • MACD
  • AMRX -0.02
  • WHD 0.41
  • Stochastic Oscillator
  • AMRX 71.19
  • WHD 83.09

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

Share on Social Networks: